Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.

Ipsen’s first clinical trial lay summary developed with patients, for patients

Ipsen and Blueprint enter exclusive agreement in FOP

Rethink liver cancer: Increase your understanding this Liver Cancer Awareness Month

Ipsen in Oncology: For us, it’s personal